Jupiter Neurosciences, Inc.Jupiter Neurosciences, Inc.Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

No trades
See on Supercharts

JUNS fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
JUNS has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company